Optimizing endovascular thrombectomy timing and thrombolysis use for ischemic stroke: insights from the SELECT2 and TIMELESS trials
- PMID: 39507459
- PMCID: PMC11534760
- DOI: 10.21037/atm-24-64
Optimizing endovascular thrombectomy timing and thrombolysis use for ischemic stroke: insights from the SELECT2 and TIMELESS trials
Keywords: Thrombectomy; ischemic stroke; stroke; thrombolysis.
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://atm.amegroups.com/article/view/10.21037/atm-24-64/coif). The authors have no conflicts of interest to declare.
Comment on
-
Endovascular thrombectomy plus medical care versus medical care alone for large ischaemic stroke: 1-year outcomes of the SELECT2 trial.Lancet. 2024 Feb 24;403(10428):731-740. doi: 10.1016/S0140-6736(24)00050-3. Epub 2024 Feb 9. Lancet. 2024. PMID: 38346442 Clinical Trial.
References
Publication types
LinkOut - more resources
Full Text Sources